As a result, when ALO targets VPS4A inhibition, the impact on the autophagic flux in NSCLC cells surpasses that in HBE cells; second, HBE cells exhibit stronger antioxidant capacity compared with NSCLC cells, thus reducing oxidative damage and apoptosis caused by ALO. Here, VPS4A is linked to non-small cell lung carcinoma.